Conclusions
-
Mean Meloxicam pharmacokinetics and bioavailability are not significantly altered relative to the fasted state when given concomitantly with food.
-
No food related changes in Meloxicam efficacy and safety will occur during treatment.
Similar content being viewed by others
References
T. Ishizaki, T. Nomura and T. Abe,Pharmacokinetics of Piroxicam, a new non-steroidal anti-inflammatory agent, under fasting and postprandial states in man J. of Pharmacokinetics and Biopharmacy7, 369–381 (1979).
Tenoxicam in perspective. Editorial development by Adis Press, 1987.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Busch, U., Heinzel, G. & Narjes, H. Effect of food on pharmacokinetics of meloxicam, a new non steroidal anti-inflammatory drug (NSAID). Agents and Actions 32, 52–53 (1991). https://doi.org/10.1007/BF01983308
Issue Date:
DOI: https://doi.org/10.1007/BF01983308